Skip to Content

Otsuka Holdings Co Ltd 4578

Morningstar Rating
JPY 6,388.00 +175.00 (2.82%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

4578 is trading at a 24% premium.
Price
JPY 6,243.88
Fair Value
JPY 2,863.35
Uncertainty
High
1-Star Price
JPY 9,918.54
5-Star Price
JPY 2,714.53
Economic Moat
Pfdcmy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 4578 is a good fit for your portfolio.

Trading Information

Previous Close Price
JPY 6,213.00
Day Range
JPY 6,348.006,534.00
52-Week Range
JPY 4,857.006,845.00
Bid/Ask
JPY 6,387.00 / JPY 6,407.00
Market Cap
JPY 3.47 Tril
Volume/Avg
2.5 Mil / 1.0 Mil

Key Statistics

Price/Earnings (Normalized)
12.94
Price/Sales
1.61
Dividend Yield (Trailing)
1.77%
Dividend Yield (Forward)
1.93%
Total Yield
1.77%

Company Profile

Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Growth
Total Number of Employees
39,548

Comparables

Valuation

Metric
4578
4554
2929
Price/Earnings (Normalized)
12.9412.807.43
Price/Book Value
1.340.822.80
Price/Sales
1.610.830.46
Price/Cash Flow
10.545.024.91
Price/Earnings
4578
4554
2929

Financial Strength

Metric
4578
4554
2929
Quick Ratio
1.530.550.81
Current Ratio
2.071.241.11
Interest Coverage
21.0758.7495.38
Quick Ratio
4578
4554
2929

Profitability

Metric
4578
4554
2929
Return on Assets (Normalized)
8.73%4.98%14.13%
Return on Equity (Normalized)
12.03%10.16%56.21%
Return on Invested Capital (Normalized)
10.68%6.17%17.85%
Return on Assets
4578
4554
2929
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
FklydxkdYrxw$842.0 Bil
Johnson & Johnson
JNJ
GjxvbtsMgz$355.7 Bil
Merck & Co Inc
MRK
JxrfrjjzYrvbh$328.4 Bil
AbbVie Inc
ABBV
XpppbxwGktlp$304.0 Bil
AstraZeneca PLC ADR
AZN
TnqggbbjQfn$244.5 Bil
Roche Holding AG ADR
RHHBY
YtdrwtqknCcgg$228.5 Bil
Novartis AG ADR
NVS
JcznmmfnNqxc$217.6 Bil
Amgen Inc
AMGN
SkqcddfwwcWtfgy$166.2 Bil
Pfizer Inc
PFE
KrznfxxcwHqms$157.2 Bil
Sanofi SA ADR
SNY
XqgbwcbqZbdbx$118.5 Bil

Sponsor Center